← Arcutis Biotherapeutics, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and Cash Equivalents, at Carrying Value | $63.3m | $65.1m | $96.4m | $53.6m | $88.4m | $71.3m | $42.9m | |
| Prepaid Expense and Other Assets, Current | $5.2m | $6.8m | $14.2m | $10.6m | $18.7m | $19.7m | $21.1m | |
| Trade receivables, net | — | — | $0 | $8.5m | $25.8m | $73.1m | $146.2m | |
| Prepaid expenses and other current assets | $5.2m | $6.8m | $14.2m | $10.6m | $18.7m | $19.7m | $21.1m | |
| Inventory, Net | — | — | $0 | $7.5m | $13.1m | $14.5m | $22.6m | |
| Assets, Current | $106.5m | $292.8m | $402.8m | $437.4m | $330.4m | $335.8m | $411.2m | |
| Total current assets | $106.5m | $292.8m | $402.8m | $437.4m | $330.4m | $335.8m | $411.2m | |
| Property, Plant and Equipment, Net | $227k | $2.0m | $2.3m | $1.9m | $1.5m | $1.0m | $1.0m | |
| Intangible Assets, Net (Excluding Goodwill) | — | — | $0 | $7.2m | $6.4m | $9.5m | $14.8m | |
| Operating Lease, Right-of-Use Asset | $264k | $3.3m | $3.0m | $2.7m | $2.4m | $2.0m | $4.5m | |
| Other Assets, Noncurrent | $47k | $78k | $78k | $78k | $596k | $596k | $1.4m | |
| Additional Financial Items | ||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | $8.5m | $25.8m | $73.1m | $146.2m | |
| Restricted cash | $0 | $1.5m | $1.5m | $1.2m | $925k | $617k | $308k | |
| Marketable securities | $37.9m | $219.4m | $290.6m | $355.9m | $183.5m | $156.6m | $178.1m | |
| Accrued and other current liabilities | $3.7m | $15.5m | $25.5m | $28.3m | $33.9m | $66.0m | $116.3m | |
| Accrued Liabilities, Current | $3.7m | $15.5m | $25.5m | $28.3m | $33.9m | $66.0m | $116.3m | |
| Total stockholders’ equity | ($65.0m) | $270.6m | $297.7m | $209.6m | $88.7m | $157.5m | $189.5m | |
| Assets | $107.0m | $298.3m | $408.2m | $449.3m | $341.4m | $348.9m | $433.0m | |
| LIABILITIES AND EQUITY | ||||||||
| Total liabilities and stockholders’ equity | $107.0m | $298.3m | $408.2m | $449.3m | $341.4m | $348.9m | $433.0m | |
| Current liabilities: | ||||||||
| Operating Lease, Liability, Current | $178k | $0 | $433k | $657k | $735k | $820k | $294k | |
| Accounts Payable, Current | $1.4m | $7.1m | $7.4m | $8.8m | $12.0m | $14.2m | $12.5m | |
| Operating Lease, Liability, Noncurrent | $129k | $5.0m | $4.8m | $4.1m | $3.4m | $2.6m | $5.3m | |
| Dividends Payable | — | $0 | $0 | $0 | — | — | — | |
| Long-term Debt, Excluding Current Maturities | — | — | $72.3m | $197.8m | $201.8m | $107.2m | $108.0m | |
| Long-term Debt, Current Maturities | — | — | — | — | — | $0 | $1.0m | |
| Current portion of long-term debt, net | — | — | — | — | — | $0 | $1.0m | |
| Liabilities, Current | $5.2m | $22.6m | $33.3m | $37.8m | $46.7m | $81.0m | $129.8m | |
| Total current liabilities | $5.2m | $22.6m | $33.3m | $37.8m | $46.7m | $81.0m | $129.8m | |
| Other Liabilities, Noncurrent | $184k | $82k | $25k | $0 | $849k | $570k | $431k | |
| Operating lease liability, long-term | $129k | $5.0m | $4.8m | $4.1m | $3.4m | $2.6m | $5.3m | |
| Long-term debt, net | — | $0 | $72.3m | $197.8m | $201.8m | $107.2m | $108.0m | |
| Other long-term liabilities | $184k | $82k | $25k | $0 | $849k | $570k | $431k | |
| Liabilities | $5.5m | $27.6m | $110.5m | $239.7m | $252.7m | $191.3m | $243.5m | |
| Stockholders’ equity: | ||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $12k | |
| Common Stock, Value, Issued | $0 | $4k | $5k | $6k | $9k | $12k | $12k | |
| Additional Paid in Capital | $1.2m | $472.6m | $706.2m | $930.4m | $1.1b | $1.3b | $1.3b | |
| Retained Earnings (Accumulated Deficit) | ($66.3m) | ($201.9m) | ($408.3m) | ($719.8m) | ($981.9m) | ($1.1b) | ($1.1b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($1k) | ($2k) | ($255k) | ($1.1m) | $4k | ($7k) | ($44k) | |
| Common stock, $0.0001 par value; 300,000,000 shares authorized; 123,332,672 and 117,848,033 shares issued and outstanding at December 31, 2025 and 2024, respectively | 0 | 4k | 5k | 6k | 9k | 12k | 12k | |
| Accumulated other comprehensive loss | ($1k) | ($2k) | ($255k) | ($1.1m) | $4k | ($7k) | ($44k) | |
| Stockholders' Equity Attributable to Parent | ($65.0m) | $270.6m | $297.7m | $209.6m | $88.7m | $157.5m | $189.5m | |
| Liabilities and Equity | $107.0m | $298.3m | $408.2m | $449.3m | $341.4m | $348.9m | $433.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.